Laurent Pharmaceuticals Receives Health Canada’s Approval to Initiate COVID-19 Clinical Trial

6 May 2020

Company to test LAU-7b’s dual pro-resolving inflammation and antiviral properties against COVID-19Laurent Pharmaceuticals Inc., a Montreal-based biopharmaceutical company, today announced that...

Read More

Laurent Pharmaceuticals Joins Battle Against COVID-19

9 April 2020

Laurent Pharmaceuticals Inc., a clinical-stage biopharmaceutical company that spun off from McGill University in 2012, today announces that it is planning...

Read More


Laurent Pharma to participate to H.C. Wainwright 23rd Annual Global Investment Conference, September 13-15, 2021